Merck/J&J deal may help US get enough vaccine for all adults by end of May
Ars Technica 2021-03-02
Summary:
Merck will dedicate two facilities to making the newly authorized J&J vaccine.
Link:
https://arstechnica.com/?p=1746636From feeds:
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific MethodCyberlaw » Ars Technica
Music and Digital Media » Ars Technica